RxDoctor Payments DataLook up a doctor →

Luisa Solis-Cohen, MD

Neurology · Littleton, CONPI 1215299193

Payments from drug & device makers

$187,910in general payments, 2019–2025

Across 1,246 payments — averaging $150.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$67K
  • MDD US Operations, LLC$44K
  • Abbott$39K
  • Adamas Pharmaceuticals, Inc.$19K
  • AbbVie$3K
  • Amneal Pharmaceuticals LLC$2K
  • plus $13K from 54 others
$870in research payments, 2019–2025

Across 1 payment — averaging $870.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$870

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Neurocrine Biosciences, Inc.148$67,339
MDD US Operations, LLC129$44,224
Abbott57$38,810
Adamas Pharmaceuticals, Inc.53$19,150
AbbVie(2 entities)193$3,481
Amneal Pharmaceuticals LLC50$1,829
Boston Scientific19$1,386
UCB, Inc.70$1,371
Pfizer46$785
AstraZeneca(2 entities)33$784
Lundbeck LLC30$563
Lilly USA, LLC32$550
Amgen(2 entities)25$539
Acadia Pharmaceuticals Inc28$535
Medtronic(2 entities)24$531
Argenx US, Inc.20$484
Biogen25$478
Tanabe Pharma America, Inc.23$453
Acorda Therapeutics, Inc19$443
SK Life Science, Inc.16$310
Novartis23$304
Sunovion Pharmaceuticals Inc.19$287
Averitas Pharma Inc.7$254
EMD Serono, Inc.11$251
Biohaven Pharmaceutical Holding Company Ltd.19$228
Sanofi13$225
Merz Pharmaceuticals, LLC7$190
Eisai Inc.14$178
Teva Pharmaceuticals USA, Inc.9$178
Jazz Pharmaceuticals Inc.7$159
Neurelis, Inc.5$131
Genentech USA, Inc.6$130
Bristol Myers Squibb5$127
Catalyst Pharmaceuticals, Inc.5$107
Kyowa Kirin, Inc.4$82
Otsuka America Pharmaceutical, Inc.3$81
Sumitomo Pharma America, Inc.5$75
Octapharma USA, Inc.3$75
Vertical Pharmaceuticals, LLC4$65
Impel Pharmaceuticals Inc.3$60
Avion Pharmaceuticals2$57
Insightec,inc2$56
Grifols USA, LLC3$51
Mallinckrodt Enterprises LLC3$50
Biohaven Pharmaceuticals, Inc.3$44
Johnson & Johnson3$42
Greenwich Biosciences, Inc.2$37
Orphalan Inc1$35
Banner Life Sciences, LLC1$32
Immedica Pharma US, Inc.1$28
Harmony Biosciences LLC1$28
GE HealthCare2$26
Philips North America LLC2$25
CSL Behring1$25
ITF Therapeutics LLC1$25
GRT US Holding, Inc.1$23
Axsome Therapeutics, Inc.1$23
ANI Pharmaceuticals, Inc.1$21
Scilex Pharmaceuticals Inc.1$18
Mallinckrodt Hospital Products Inc.1$17

How this compares

$187,910 in reported general payments places this provider in the 85th percentile of 334 neurology providers in Colorado.

See all neurology providers in Colorado

Medicare billing

Part B allowed, 2024
$143,396
Medicare patients
306
Services billed
5,473

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Littleton

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →